
3Spine announces the completion of enrollment for the MOTUS clinical trial, marking a major milestone in bringing this groundbreaking motion-preserving alternative to spinal fusion closer to FDA approval and widespread availability for patients.
Submit your information below and one of our spine motion specialists will contact you in the next 24-48 hours.

3Spine announces the completion of enrollment for the MOTUS clinical trial, marking a major milestone in bringing this groundbreaking motion-preserving alternative to spinal fusion closer to FDA approval and widespread availability for patients.